Late anthracycline cardiotoxicity in patients treated for childhood acute lymphoblastic leukemia
Introduction: advances in the treatment of childhood acute lymphoblastic leukemia give a greater life expectancy for these patients. As the number of survivors increase, more long-term adverse effects are detected. Among the most frequent adverse effects stands late anthracycline cardiotoxicity (dox...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Editorial Ciencias Médicas
2013-10-01
|
Series: | Acta Médica del Centro |
Subjects: | |
Online Access: | http://www.revactamedicacentro.sld.cu/index.php/amc/article/view/4 |